Holen Sie sich die Stockscreener-App
21.79
1.68%
0.37
Schlusskurs vom Vortag:
$21.42
Offen:
$21.44
24-Stunden-Volumen:
423.32K
Relative Volume:
0.17
Marktkapitalisierung:
$2.78B
Einnahmen:
$642.82M
Nettoeinkommen (Verlust:
$-43.54M
KGV:
-62.33
EPS:
-0.3496
Netto-Cashflow:
$130.12M
1W Leistung:
-16.49%
1M Leistung:
+9.94%
6M Leistung:
+58.17%
1J Leistung:
+162.09%
1-Tages-Spanne:
$21.23
$21.92
1-Wochen-Bereich:
$20.62
$26.10
52-Wochen-Spanne:
$7.72
$26.45
10 X Genomics Inc Stock (TXG) Company Profile
Firmenname
10 X Genomics Inc
Sektor
Branche
Telefon
(925) 401-7300
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, TEM, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
21.76 | 2.74B | 642.82M | -43.54M | 130.12M | -0.3496 |
VEEV
Veeva Systems Inc
|
158.19 | 25.50B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
47.91 | 9.12B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
51.17 | 9.23B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
81.03 | 6.57B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
25.24 | 4.77B | 1.10B | 112.09M | 283.19M | 0.6096 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | Eingeleitet | Piper Sandler | Neutral |
| 2025-02-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-22 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-05-01 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-10 | Eingeleitet | Barclays | Overweight |
| 2023-03-31 | Eingeleitet | Stephens | Overweight |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-08-18 | Herabstufung | Goldman | Neutral → Sell |
| 2022-07-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-07-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-10 | Eingeleitet | Stifel | Buy |
| 2020-03-05 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-07 | Eingeleitet | BofA/Merrill | Buy |
| 2019-10-07 | Eingeleitet | Cowen | Outperform |
| 2019-10-07 | Eingeleitet | JP Morgan | Overweight |
| 2019-09-24 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
Why 10x Genomics (TXG) Shares Are Trading Lower Today - Yahoo Finance
10x Genomics seen as key player in AI-driven biological data buildout - MSN
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - MSN
10X Genomics Hits New 52-Week High at $25.69, Showcasing Market Resilience - Markets Mojo
10X Genomics Experiences Evaluation Revision Amid Strong Market Performance and Volatility - Markets Mojo
10x Genomics debuts Atera, a new platform to redefine how biology is measured and understood at AACR 2026 - Select Science
10X Genomics Hits New 52-Week High of $26.44, Reflecting Strong Growth - Markets Mojo
10x Genomics Stock Up on Atera Launch, Spatial Biology Scale Enhanced - Yahoo Finance
10x Genomics (TXG) Launches Atera: A Breakthrough in Spatial Bio - GuruFocus
10x Genomics Launches Atera Platform for Spatial Biology - Intellectia AI
10x opens Atera pre-orders for cell-by-cell mapping across whole tissues - Stock Titan
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood - PR Newswire
10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets Mojo
Best Genomics Stocks for 2026 and How to Invest - The Motley Fool
10X Genomics stock hits 52-week high at 26.07 USD By Investing.com - Investing.com India
10X Genomics stock hits 52-week high at 26.07 USD - Investing.com
TXG Stock Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
10x Genomics (NASDAQ: TXG) CEO sells 5,000 shares in 10b5-1 trade - Stock Titan
TXG Stock Price, Quote & Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
10x Genomics (TXG) Stock Regulatory Filing (Investor Interest) 2026-04-15Retail Money Flow - Cổng thông tin điện tử tỉnh Tây Ninh
10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026 - 富途牛牛
10X Genomics Experiences Evaluation Revision Amidst Mixed Market Signals and Strong Performance - Markets Mojo
10x Genomics $TXG Stake Boosted by Tudor Investment Corp ET AL - MarketBeat
10x Genomics Is Maintained at Overweight by Barclays - Moomoo
Is It Too Late To Consider 10x Genomics (TXG) After Its 185% One-Year Surge? - simplywall.st
10x Genomics $TXG Shares Bought by Sumitomo Mitsui Trust Group Inc. - MarketBeat
10x Genomics (NASDAQ:TXG) Hits New 12-Month HighWhat's Next? - MarketBeat
Form 8-KCurrent report - ADVFN
Best Genetic Sequencing Stocks for 2026 and How to Invest in Them - The Motley Fool
TXG (10x Genomics) Receipts from Customers - GuruFocus
TXG (10x Genomics) Short-term investments - GuruFocus
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
10X Genomics Hits New 52-Week High of $23.60, Reflecting Strong Growth - Markets Mojo
10x Genomics stock hits 52-week high at 23.6 USD By Investing.com - Investing.com Canada
10x Genomics, Inc. (TXG) Stock Price, News, Quote & History - Yahoo! Finance Canada
10x Genomics stock hits 52-week high at 23.6 USD - Investing.com
Go Beyond Bulk with Single-Cell RNA-Seq - the-scientist.com
10x Genomics, Inc. (TXG) stock price, news, quote and history - Yahoo Finance Singapore
A Look At 10x Genomics (TXG) Valuation After Recent Share Price Momentum - Yahoo Finance
Why 10x Genomics (TXG) Is Up 14.6% After Analyst Upgrade And New AI Data Initiative - Yahoo Finance
10x Genomics Inc. (TXG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
10x Genomics Inc. (US88025U1097.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
William Blair upgrades 10x Genomics (TXG) - MSN
10x Genomics (TXG) Receives Upgrade to 'Outperform' by William B - GuruFocus
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
10 X Genomics Inc-Aktie (TXG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Saxonov Serge | Chief Executive Officer |
Mar 23 '26 |
Sale |
19.13 |
10,000 |
191,297 |
1,177,273 |
| Saxonov Serge | Chief Executive Officer |
Mar 24 '26 |
Sale |
19.52 |
5,000 |
97,612 |
1,172,273 |
| Saxonov Serge | Chief Executive Officer |
Mar 02 '26 |
Sale |
22.73 |
16,152 |
367,097 |
1,203,667 |
0.32%
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):